Modèles transgéniques pour l'étude de la fonction ... - Epublications

Brink, R., Goodnow, C. C., Crosbie, J., Adams, E., Eris, J., Mason, D. Y., Hartley, S.
B. and Basten, A. (1992). Immunoglobulin M and D antigen receptors are both capable of
mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J
Exp Med 176, 991-1005.
Brockhausen, I., Reck, F., Kuhns, W., Khan, S., Matta, K. L., Meinjohanns, E.,
Paulsen, H., Shah, R. N., Baker, M. A. and Schachter, H. (1995). Substrate specificity and
inhibition of UDP-GlcNAc:GlcNAc beta 1-2Man alpha 1-6R beta 1,6-Nacetylglucosaminyltransferase
V using synthetic substrate analogues. Glycoconj J 12, 371-9.
Bruce, S. R., Dingle, R. W. and Peterson, M. L. (2003). B-cell and plasma-cell splicing
differences: a potential role in regulated immunoglobulin RNA processing. Rna 9, 1264-73.
Buck, D., Malivert, L., de Chasseval, R., Barraud, A., Fondaneche, M. C., Sanal, O.,
Plebani, A., Stephan, J. L., Hufnagel, M., le Deist, F. et al. (2006). Cernunnos, a novel
nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly.
Cell 124, 287-99.
Buhl, A. M. and Cambier, J. C. (1999). Phosphorylation of CD19 Y484 and Y515, and
linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptormediated
activation of Bruton's tyrosine kinase. J Immunol 162, 4438-46.
Burkhardt, A. L., Brunswick, M., Bolen, J. B. and Mond, J. J. (1991). Antiimmunoglobulin
stimulation of B lymphocytes activates src-related protein-tyrosine kinases.
Proc Natl Acad Sci U S A 88, 7410-4.
Calame, K. L., Lin, K. I. and Tunyaplin, C. (2003). Regulatory mechanisms that
determine the development and function of plasma cells. Annu Rev Immunol 21, 205-30.
Cambier, J. C., Newell, M. K., Justement, L. B., McGuire, J. C., Leach, K. L. and
Chen, Z. Z. (1987). Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B
lymphocytes. Nature 327, 629-32.
Cariappa, A. and Pillai, S. (2002). Antigen-dependent B-cell development. Curr Opin
Immunol 14, 241-9.
Carter, P. J. (2006). Potent antibody therapeutics by design. Nat Rev Immunol 6, 343-57.
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P. and
Watier, H. (2002). Therapeutic activity of humanized anti-CD20 monoclonal antibody and
polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood 99, 754-8.
Casola, S. (2007). Control of peripheral B-cell development. Curr Opin Immunol 19,
143-9.
Casola, S., Otipoby, K. L., Alimzhanov, M., Humme, S., Uyttersprot, N., Kutok, J.
L., Carroll, M. C. and Rajewsky, K. (2004). B cell receptor signal strength determines B cell
fate. Nat Immunol 5, 317-27.
Chan, A. C., Iwashima, M., Turck, C. W. and Weiss, A. (1992). ZAP-70: a 70 kd
protein-tyrosine kinase that associates with the TCR zeta chain. Cell 71, 649-62.
Chan, V. W., Meng, F., Soriano, P., DeFranco, A. L. and Lowell, C. A. (1997).
Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in
signal initiation and down-regulation. Immunity 7, 69-81.
Chaudhuri, J. and Alt, F. W. (2004). Class-switch recombination: interplay of
transcription, DNA deamination and DNA repair. Nat Rev Immunol 4, 541-52.
Chaudhuri, J., Khuong, C. and Alt, F. W. (2004). Replication protein A interacts with
AID to promote deamination of somatic hypermutation targets. Nature 430, 992-8.
Chaudhuri, J., Tian, M., Khuong, C., Chua, K., Pinaud, E. and Alt, F. W. (2003).
Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature
422, 726-30.
155